Product Details
Braftovi 50 mg Capsules**
Encorafenib50 mg
Capsule
ROA
Oral
Applicant Name
Pfizer Specialties Ltd
NRN
A4-100330
Status
Active
Composition
Each hard capsule contains: Encorafenib 50 mg. Excipients: Capsule content - Copovidone (E1208) Poloxamer 188 Cellulose microcrystalline (E460i) Succinic acid (E363) Crospovidone (E1202) Silica colloidal anhydrous (E551) Magnesium stearate (E470b) Capsule shell - Gelatin (E441) Titanium dioxide (E171) Iron oxide red (E172) Iron oxide yellow (E172) Iron oxide black (E172)
ATC Code
L01EC03
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
28's (in polyamide/aluminium/PVC/aluminium/ PET/paper perforated unit dose blisters)
Product Description
Hard capsule (capsule). Orange opaque cap and flesh opaque body, printed with a stylised “A” on the cap and “LGX 50mg” on the body. The length of the capsule is approximately 22 mm
Manufacturer Name
Catalent Pharma Solutions LLC
Manufacturer Country
UNITED STATES OF AMERICA
Approval Date
2023-01-26
Expiry Date
2028-01-25